Clinical Trial Update: A Study of Ganfort Versus Duotrav in Patients With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 study comparing Ganfort versus Duotrav in patients with primary open-angle glaucoma or ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• DuoTrav (travoprost; timolol (fixed-dose combination))
• Ganfort (bimatoprost; timolol)

Snippet

Sponsor: Ministry of Health, Malaysia | Conditions: Ocular Hypertension, Primary Open Angle Glaucoma | Phase 3 | Status: COMPLETED